Les Meilleures Cliniques et Coûts des traitements d'hépatite C en Inde 2026

Hepatitis C is curable in India with success rates exceeding 95% using oral medications. Patients typically clear the virus within 12 weeks of daily treatment. Indian centers utilize Direct-Acting Antivirals (DAAs) like Sofosbuvir and Velpatasvir to achieve sustained virologic response.

• Treatment success: Success rates consistently exceed 95% with modern oral regimens.
• Recovery timeline: Viral clearance is typically achieved within 12 weeks of therapy.
• Specialized expertise: Clinics like Artemis Hospitals maintain JCI and NABH accreditations.
• Advanced diagnostics: Facilities use PCR tests and liver scans for baseline assessments.

Bookimed Expert Insight: India ranks second globally in our network for patient requests. This volume is driven by experts like Dr. Yogesh Batra at BLK Super Speciality Hospital. He has over 20 years of experience in hepatology. High patient flow allows these specialists to manage complex cases with proven protocols.

Patient Consensus: Patients value how quickly hospitals organize everything from airport transfers to medication sourcing. Many note that getting genotyped at reputable labs is essential before starting the 3-month course.

Indian generic drugs are as effective as brand-name versions like Sovaldi. Clinical research shows matching 90% viral suppression rates within four weeks. Generic sofosbuvir provides identical cure rates. Major Indian manufacturers maintain World Health Organization and US FDA certifications for global safety standards.

• Success rates: Patients report cure rates over 95% using Indian generic combinations.
• Viral load: Undetectable viral loads are achieved in 90% of patients after one month.
• Manufacturing standards: India hosts over 750 facilities certified by the US FDA.
• Official licensing: Gilead Sciences provided voluntary licenses to ensure generics follow innovator standards.

Bookimed Expert Insight: While patients often focus on the drug name, the real quality signal in India is the hospital's diagnostic infrastructure. Facilities like Apollo Hospital Indraprastha and Manipal Hospitals Bengaluru serve millions of patients annually and use advanced testing to confirm SVR12. Success depends on selecting the right combination for your specific genotype before starting the 8-to-12 week course.

Patient Consensus: Patients note that generic combinations like sofosbuvir and daclatasvir work effectively across different genotypes. Many emphasize that following up with Fibroscan tests post-treatment confirms significant liver improvement and fibrosis regression.

India specializes in treating Hepatitis C using direct-acting antiviral (DAA) medications. These drugs target the virus directly to achieve cure rates exceeding 95%. Generic medications officially produced in India under license include Sofosbuvir, Daclatasvir, and Velpatasvir. These options treat various genotypes effectively and safely.

• Standard combination: Sofosbuvir and Daclatasvir treat genotypes 1 through 6 efficiently.
• Pan-genotypic coverage: Sofosbuvir plus Velpatasvir serves as a universal treatment option.
• Shortened regimens: Generic Glecaprevir and Pibrentasvir may reduce treatment to 0.5 months.
• Primary specialists: Hepatologists like Dr. Yogesh Batra lead treatment at JCI-accredited facilities.

Bookimed Expert Insight: Indian clinics like Medanta and Artemis Hospitals provide massive capacity for international patients. Our data shows hospitals like Manipal serve 2,000,000 patients annually. This high volume allows doctors to manage complex cirrhosis cases alongside standard antiviral therapy. Patients often choose Delhi or Gurgaon for easier access to large medical networks.

Patient Consensus: Patients emphasize the importance of genotype testing before starting any generic medication. Many note that coordinating pharmacy pickups through hospital translators makes the process much smoother.

Hepatitis C treatment in India primarily uses direct-acting antivirals. These drugs are generally safe and effective. Most patients report only mild side effects like fatigue or headaches. These symptoms typically resolve as the body adjusts. Major complications are rare for most treatment regimens.

• Gastrointestinal response: Patients may experience mild nausea or appetite loss.
• Neurological effects: Fatigue and brain fog are the most common reported symptoms.
• Treatment timeframe: Most side effects emerge during the first 2-4 weeks.
• Liver function: Temporary elevation in liver enzymes can occur during active treatment.

Bookimed Expert Insight: Patient data shows that clinics like Medanta Hospital and Apollo Hospital Indraprastha handle over 1,000,000 patients annually. High patient volumes allow Indian hepatologists like Dr. Yogesh Batra to manage complex cases with fewer complications. We see that clinics with JCI and NABH accreditations maintain the most consistent safety records during long-term antiviral protocols.

Patient Consensus: Patients often note that while tiredness and headaches are common early on, these feelings usually vanish quickly once the treatment course is finished. Many recommend staying hydrated and resting more during the first month to manage the initial adjustment period.

Foreigners can legally enter India for Hepatitis C treatment using a specialized e-Medical Visa. This process allows access to highly effective generic Direct-Acting Antivirals (DAAs). These medications provide success rates exceeding 90%. Patients typically require an official invitation letter from an accredited Indian facility.

• Entry permits: Apply for the e-Medical Visa online for 60-day triple entry.
• Generic reliability: Manufacturers like Mylan and Natco produce WHO-approved DAAs under license.
• Treatment duration: Initial onsite testing takes 7–9 days before starting medication at home.
• Hospital network: JCI-accredited centers like Apollo Hospital Indraprastha serve over 1,000,000 patients yearly.

Bookimed Expert Insight: India’s healthcare landscape provides a massive volume of liver care, with Apollo Hospital Indraprastha hosting the largest transplantation center outside the US. This high surgical and clinical volume translates to clinicians who manage hundreds of complex viral cases monthly. For Hepatitis C, this expertise ensures precise staging before you buy medications, preventing expensive drug resistance issues later.

Patient Consensus: Patients emphasize purchasing medications directly through the prescribed clinic to guarantee authenticity. They also recommend documenting a detailed treatment protocol in writing to share with doctors back home for remote monitoring.